Exane Derivatives’s B2Gold BTG Stock Holding History
Bought
Maintained
Sold
Other funds holding BTG
Exane Derivatives's BTG Position: Q2 2022 in Review
Exane Derivatives reduced its B2Gold (BTG) stake by 0.69% in Q2 2022, selling an estimated $4.46K and leaving 154,138 shares worth $522K. The position accounts for 0.3% of the portfolio, ranked #82.
Exane Derivatives first reported a position in BTG in Q1 2022 and has held it in 2 quarters since. The position peaked at $712K in Q1 2022. 217 funds tracked by Wall St. Rank hold BTG as of Q2 2022.
- Exane Derivatives held 154,138 shares of B2Gold worth $522K as of Q2 2022.
- Exane Derivatives sold 1,067 B2Gold shares in Q2 2022, an estimated $4.46K.
- B2Gold made up 0.3% of Exane Derivatives's portfolio in Q2 2022, its #82 holding.
- Exane Derivatives first reported a position in B2Gold in Q1 2022 and has held it in 2 quarters since.
- Exane Derivatives's B2Gold position peaked at $712K in Q1 2022.
- 217 funds tracked by Wall St. Rank held B2Gold as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.